DIFFERENT BY DESIGN
Each patient’s journey is unique.
Every product requires a new roadmap.
Let’s connect the dots together.
PX3 AXS is transforming the possibilities
We’re making a real difference—backed by real results—in launching complex oncology and rare disease products.
Our mission is to provide trailblazing solutions for novel medicines to transform the patient experience.
Organizations are turning to PX3 AXS and our renowned thought leadership. Where strategic goals are aligned with insights and data to build custom commercialization frameworks.
DIFFERENT BY DESIGN
Each patient’s journey is unique.
Every product requires a new roadmap.
Let’s connect the dots together.
PX3 AXS is transforming the possibilities
We’re making a real difference—backed by real results—in launching complex oncology and rare disease products.
Our mission is to provide trailblazing solutions for novel medicines to transform the patient experience.
Organizations are turning to PX3 AXS and our renowned thought leadership. Where strategic goals are aligned with insights and data to build custom commercialization frameworks.
TAILOR-MADE ROADMAPS FOR SUCCESS
Our client-work features unrivaled strategic ideas that have shattered barriers once believed impassable. Major advances in technology have paved the way for novel products to be introduced, ranging from new treatments for ultra-rare conditions to personalized cancer therapies.
The complexity of novel products requires us to rethink the entire commercialization model, redefine how value should be articulated, and most importantly, integrate perspectives in formation of the optimal patient experience.
TAILOR-MADE ROADMAPS FOR SUCCESS
Our client-work features unrivaled strategic ideas that have shattered barriers once believed impassable. Major advances in technology have paved the way for novel products to be introduced, ranging from new treatments for ultra-rare conditions to personalized cancer therapies.
The complexity of novel products requires us to rethink the entire commercialization model, redefine how value should be articulated, and most importantly, integrate perspectives in formation of the optimal patient experience.
BUILD COMMERCIALIZATION STRATEGIES
The questions often start with the fundamentals due to the complexity of these novel therapies and often not well-understood conditions.
REDEFINE VALUE AND ACCESS
The payer approach to an assessment of a product’s value is still based on traditional clinical trial design and process to review safety and efficacy data, as well as costs. However, novel treatments often require clinical trial programs to be conducted utilizing unconventional methods due to the complexities of the technologies, limited patient populations, and lack of appropriate comparators.
MASTER PATIENT EXPERIENCES
For novel treatments, the key to success is building a superior patient experience throughout the treatment journey and beyond.
BUILD COMMERCIALIZATION STRATEGIES
The questions often start with the fundamentals due to the complexity of these novel therapies and often not well-understood conditions.
REDEFINE VALUE AND ACCESS
The payer approach to an assessment of a product’s value is still based on traditional clinical trial design and process to review safety and efficacy data, as well as costs. However, novel treatments often require clinical trial programs to be conducted utilizing unconventional methods due to the complexities of the technologies, limited patient populations, and lack of appropriate comparators.
MASTER PATIENT EXPERIENCES
For novel treatments, the key to success is building a superior patient experience throughout the treatment journey and beyond.
BIG IDEAS…
BOUTIQUE IDEALS
Clients partner with us because we listen to their needs and unique challenges. No two strategies are ever exactly alike. Our highly experienced team is reshaping the future of commercialization—one disease at a time.
The PX3 AXS members you meet from day one will be your team all along the way. We’re big proponents of building the right chemistry with our partners.
Our collaborative group was carefully considered to help clients who share our same fearless vision—to create revolutionary patient experiences. Together.
BIG IDEAS…
BOUTIQUE IDEALS
Clients partner with us because we listen to their needs and unique challenges. No two strategies are ever exactly alike. Our highly experienced team is reshaping the future of commercialization—one disease at a time.
The PX3 AXS members you meet from day one will be your team all along the way. We’re big proponents of building the right chemistry with our partners.
Our collaborative group was carefully considered to help clients who share our same fearless vision—to create revolutionary patient experiences. Together.
We’re:
Passionate
about making a real
difference in rare
disease products
Experienced
in shaping complex
launches in the
sciences
Focused
on translating insights into actionable strategies
Unrivaled
with
breakthrough
thinking
Dedicated
to providing
superior client
service
We’re:
Passionate
about making a real
difference in rare
disease products
Experienced
in shaping complex
launches in the
sciences
Focused
on translating
insights into
actionable strategies
Unrivaled
with
breakthrough
thinking
Dedicated
to providing
superior client
service
OUR LATEST PERSPECTIVES
Discover the topics we’re passionate about and stay up to date on the latest trends. Our dedicated team of thought leaders are actively offering unique insights and events when it comes to commercialization, rare diseases, patient journeys, strategic planning, and more.
CONNECT WITH US
Let’s chat about your organization’s goals and how PX3 AXS can help you to redefine the entire patient journey in rare diseases and oncology.
Email or call Renata Reis, Managing Director.
Or send us a note. We’d love to hear from you.